|
Market Closed -
London S.E.
19:35:24 23/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 9.700 GBX | 0.00% |
|
-2.02% | -2.02% |
| 08-19 | EARNINGS AND TRADING: Cooks sales up; Amcomri profit rises, debt falls | AN |
| 08-19 | UK Regulator Allows Scancell Holdings to Launch Late-stage Trial for Advanced Melanoma Therapy | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCANCELL HOLDINGS PLC | Other Biotechnology & Medical Research | 0.00% | -2.02% | -2.02% | +1.89% | -55.91% | 157M |  |  | |
- Stock Market
- Stocks
- SCLP Stock
- Charts Scancell Holdings plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
